P. Genne

发表

Confluence‐dependent resistance in human colon cancer cells: Role of reduced drug accumulation and low intrinsic chemosensitivity of resting cells

B. Chauffert, M. Dimanche-Boitrel, H. Pelletier, 1992, International journal of cancer.

Non-invasive Imaging in Drug Discovery and Development — Where to Begin ?

P. Walker, B. Pichler, C. Berthet, 2022 .

Multicentric evaluation of the MDR phenotype in leukemia

J. Rossi, F. Pinguet, B. Drénou, 1997, Leukemia.

Circumvention of confluence‐dependent resistance in a human multi‐drug‐resistant colon‐cancer cell line

B. Chauffert, C. Garrido, P. Genne, 1995, International journal of cancer.

Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes

B. Chauffert, E. Solary, P. Fenaux, 2000, Leukemia.

Mitoxantrone/Cytarabine with or without Quinine as a Potential MDR- Reversing Agent for the Treatment of Acute Leukemias

E. Solary, P. Moreau, N. Ifrah, 1996 .

Effects of cyclosporin at various concentrations on dexamethasone intracellular uptake in multidrug resistant cells

E. Solary, P. Genne, J. Maillefert, 2000, Annals of the rheumatic diseases.

Avastin alone or combined to Campto ® reduces local Blood Oxygen Saturation in an orthotopic human glioblastoma model ( U 87-MG ) in nude rats

C. Segebarth, E. Barbier, T. Christen, 2008 .

Rationale supporting the use of vasoconstrictors for intraperitoneal chemotherapy with platinum derivatives.

B. Chauffert, P. Rat, P. Genne, 2003, Surgical oncology clinics of North America.

F11C antigen: A membrane marker able to distinguish two regressive and progressive variants from a rat colon adenocarcinoma

R. Oriol, P. Genne, N. Olsson, 1990, International journal of cancer.

MDR1 and thymidylate synthase (TS) gene expressions in advanced breast cancer: relationships to drug exposure, p53 mutations, and clinical outcome of the patients.

S. Lizard-Nacol, P. Fargeot, P. Genne, 1999, Anticancer research.

Cinchonine per os: efficient circumvention of P-glycoprotein-mediated multidrug resistance.

B. Chauffert, E. Solary, J. Magnette, 1995, Anti-cancer drug design.

Comparative effects of quinine and cinchonine in reversing multidrug resistance on human leukemic cell line K562/ADM.

B. Chauffert, E. Solary, P. Genne, 1994, Leukemia.

Cinchonine, a potent efflux inhibitor to circumvent anthracycline resistance in vivo.

B. Chauffert, P. Genne, J. Petit, 1992, Cancer research.

Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts

H. Gourdeau, O. Duchamp, P. Genne, 2002, Cancer Chemotherapy and Pharmacology.

Mechanisms of resistance of confluent human and rat colon cancer cells to anthracyclines: alteration of drug passive diffusion.

B. Chauffert, M. Manfait, J. Millot, 1990, Cancer research.

Confluence dependent resistance (CDR) to doxorubicin and E-cadherin expression in murine mammary cells.

B. Chauffert, M. Dimanche-Boitrel, O. Duchamp, 1994, Cancer letters.

The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.

Y. Pommier, E. Solary, F. Goldwasser, 1995, Leukemia.

Temozolomide and radiotherapy antitumor efficacy evaluation with magnetic resonance imaging and proton magnetic resonance spectroscopy in human glioma models in nude rats

P. Maingon, P. Walker, O. Duchamp, 2008 .

VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases

B. Ryffel, R. Gallo, G. Uzan, 2007, Proceedings of the National Academy of Sciences.

Cancer Boom

B. Chauffert, S. Bonvalot, C. Garrido, 1994, Environmental Health Perspectives.

Deleterious effect of serum proteins on the amphotericin B-induced potentiation of cisplatin in human colon cancer cells.

B. Chauffert, S. Bonvalot, M. Dimanche-Boitrel, 1994, British Journal of Cancer.

Use of a specific monoclonal antibody for studying the liver metastatic invasion of a rat colon cancer.

B. Chauffert, A. Hammann, H. Pelletier, 1988, In vivo.

Cellular pharmacology of azatoxins (topoisomerase‐II and tubulin inhibitors) in P‐glycoprotein‐positive and ‐negative cell lines

Y. Pommier, E. Solary, F. Goldwasser, 1995, International journal of cancer.

Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti‐angiogenic drug effects

Thomas Christen, Benjamin Lemasson, Christoph Segebarth, 2011, NMR in biomedicine.

A virus-directed enzyme prodrug therapy (VDEPT) strategy for lung cancer using a CYP2B6/NADPH-cytochrome P450 reductase fusion protein

Laurent Corcos, L. Corcos, P. Beaune, 2005, Cancer Gene Therapy.

French multicentric evaluation of mdr1 gene expression by RT-PCR in leukemia and solid tumours. Standardization of RT-PCR and preliminary comparisons between RT-PCR and immunohistochemistry in solid tumours

F. Pinguet, P. Validire, J. Kouyoumdjian, 1997, Leukemia.

Histological reactivity of a monoclonal antibody against rat colon cancer cells on human and rat normal gut and colonic tumours

A. Hammann, R. Oriol, P. Genne, 2005, Virchows Archiv A.

In-vivo metabolic characterization of healthy prostate and orthotopic prostate cancer in rats using proton magnetic resonance spectroscopy at 4.7 T

P. Walker, F. Brunotte, O. Duchamp, 2013, Acta radiologica.

OncoSNIPE® Study Protocol, a study of molecular profiles associated with development of resistance in solid cancer patients

N. Girard, R. Boidot, J. Iovanna, 2022, BMC cancer.

E V ects of cyclosporin at various concentrations on dexamethasone intracellular uptake in multidrug resistant cells

E. Solary, P. Genne, J. Maillefert, 2000 .

ects of cyclosporin at various concentrations on dexamethasone intracellular uptake in multidrug resistant cells

E. Solary, P. Genne, J. Maillefert, 2000 .

mdr 1 gene-expression and villin synthesis in a colon cancer cell line differentiated by sodium butyrate.

B. Chauffert, P. Genne, J. Petit, 1993, Anticancer research.

Multiparametric MRI Characterization of Six Glioma Models-Link to Carmustine Treatment Outcome

C. Segebarth, E. Barbier, O. Duchamp, 2009 .

Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti‐angiogenic drug effects

C. Segebarth, E. Barbier, T. Christen, 2011, NMR in biomedicine.